Skip to content

Effects of Eye-Tracking Technology on Attention Deficit in Stroke

Effects of Eye-Tracking Technology on Attention Deficit in Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123491
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control Group:onventional Cognitive Training: 15 min/session, twice daily, 5 days/week for 4 weeks
Conventional Occupational Therapy: 30 min/session, once daily, 5 days/week for 4 weeks.
Experimental Group:Eye-Tracking Cognitive Rehabilitation: 15 min/session, once daily, 5 days/week for 4 weeks
Conventional Cognitive Training: once daily, 5 days/week for 4 weeks

Sponsors

China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Eligibility Criteria (1)Patients with first-ever right hemisphere lesions diagnosed with cerebrovascular disease in accordance with the diagnostic criteria established at the 4th National Academic Conference on Cerebrovascular Diseases, confirmed by CT or MRI; (2)1 to 6 months after stroke onset with stable medical condition; (3)Aged 18 to 70 years old; (4)Educational level of junior high school or above; (5)Ability to maintain independent sitting position for >=30 minutes; (6)Montreal Cognitive Assessment (MoCA) score of 18 to 26 points with attention subscore < 6 points; (7)Patients' self-reported difficulty in concentration or caregivers' observation of obvious inattention in daily life; (8)Intact visual field or normal visual field after correction; (9)Patients or their legal representatives voluntarily agree to participate in the study, comply with research procedures, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1)A prior history of neurological disease, brain injury, or psychiatric illness. (2)Severe complications, cardiopulmonary disease, uncontrolled hypertension, severe physical deformity, multiple organ damage or vital organ dysfunction, severe spasticity, etc. (3)Deterioration of condition, occurrence of new infarcts or hemorrhagic lesions; development of epilepsy or consciousness disturbance. (4)Drug abuse or chronic alcohol dependence. (5)Intracranial metal objects, intracranial tumors, intracranial infection, or any clinically significant/unstable medical disease. (6)Infection. (7)Contraindications for fNIRS measurement (e.g., skull defects or abnormalities). (8)Current use of medications that may affect cognitive function, such as antipsychotics or antidepressants. (9)Inability to cooperate with assessments or rehabilitation training. (10)Visual impairment and visual field defects; patients with hemispatial neglect. (11)Participation in other related research within the past 2 months.

Design outcomes

Secondary

MeasureTime frame
The span of attention was measured using the digit span test;Rapid Visual Digit Presentation Task;Stroop color-word test;Trail Making Test Part B;Paced Auditory Serial Addition Test;Montreal Cognitive Assessment;Activities of Daily Living;Detection of a Cognitive Rehabilitation Training System Based on Eye-Tracking Technology;

Primary

MeasureTime frame
Mini-Mental State Examination;Functional Near-Infrared Brain Imaging;

Countries

China

Contacts

Public ContactJinqin Zhang

China Rehabilitation Research Center

m13051384533@163.com+86 130 5138 4533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026